To further understand the clinical significance of FOXP3 expression in breast cancer cells, we characterized a recently developed gene expression dataset with 4010 breast tumor sets from NCBI Gene Expression Omnibus (GEO) database and a subset of the samples (n = 1372) that has recurrence-free survival data available [36]. This evidence concerns the gene FOXP3 and breast carcinoma.